Table 3 Percentage of good treatment outcomes among achalasia subtypes

From: Advances in the management of oesophageal motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes

Study

Patients included

Treatment

Type I achalasia (n)

Type II achalasia (n)

Type III achalasia (n)

Pandolfino et al. (2008)18

99

• PD

• LHM

• Botulinum toxin type A

56% (21)

96% (49)

29% (29)

Salvador et al. (2010)21

246

LHM

85% (96)

95% (127)

69% (23)

Pratap et al. (2011)22

51

PD

63% (24)

90% (24)

33% (3)

Rohof et al. (2013)23

176

RCT of PD and LHM

• PD: 86%

• LHM: 81% (44)

• PD: 100%

• LHM: 95% (114)

• PD: 40%

• LHM: 86% (18)

  1. Definitions of a good outcome are variable among the reports, but type II patients consistently achieved the best outcomes and type III the worst. PD, pneumatic dilation; LHM, laparoscopic Heller myotomy; RCT, randomized controlled trial.
PowerPoint slide
Back to article page